Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

DIASOURCE

Develops, manufactures, and markets clinical diagnostic products that focus on endocrinology and infectious diseases read more Featured Products: More products

Download Mobile App





DiaSource Presents New Trio of ELISA Instruments

By LabMedica International staff writers
Posted on 11 Nov 2024

DiaSource ImmunoAssays S. More...

A. (Walloon Brabant, Belgium) is showcasing its full product range, from ELISA and RIA tests to antibodies and cutting-edge instruments at MEDICA 2024.

DiaSource is also announcing the addition of a new rapid test (POCT) and its respective reader to its portfolio. These products complete the company’s panel with additional technologies and interesting parameters in the fields of women’s health, tumor markers, drugs of abuse, infectious diseases, and cardiac markers. DiaSource is also launching a series of new antibodies in the fields of Alzheimer's disease, cardiac markers, diabetes, and fertility. These antibodies have proven to be reliable raw materials in the manufacturing of immunoassays such as CLIA, ELISA, FIA, and POCT.

At this year’s MEDICA, DiaSource is highlighting the new version of its ELISA reader, washer, and shaker. DiaSource’s new range of instruments for manual ELISA tests include the ELISA Plate Reader (DIA2000), ELISA Plate Washer (DIA3000), and ELISA Plate Shaker (DIA4000). These instruments now have a modern, sophisticated look, with an improved user interface designed to simplify the laboratory's operations and streamline data management. The ELISA Plate Reader (DIA2000), now IVDR compliant, is designed according to the principle of enzyme-linked immunoassay technology. Developed with a vertical 8-channel optical path, it can be used for single and dual wavelength measurements. The advantage is to provide absorbance, qualitative, and quantitative test results.

The ELISA Plate Washer (DIA3000) is a laboratory device specially used for cleaning microplates and performing the wash step in an ELISA procedure. It is generally used in conjunction with the ELISA Plate Reader. The user-friendly operating system allows customization of various parameters such as plate type, number of washes, wash solution quantity, plate washing method, suction point, soaking and stirring time. Its outstanding performance results in residual volumes of less than 1µl, using a 2-point aspiration process to help better achieve these precise results. The ELISA Plate Shaker (DIA4000) is mainly used for shaking and heating ELISA microplates during the incubation step of an ELISA procedure. In terms of heating, the advantage of this shaker is that it can heat both the top and bottom of the cover, significantly improving the temperature uniformity of the microplate. It also has a good sealing system to ensure that the temperature remains stable throughout the incubation period.

Related Links:
DiaSource ImmunoAssays S.A.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.